Fig. 2From: Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinomaKaplan-Meier survival analyses with log-rank test for OS and PFS of SCCHN patients with locoregional recurrenceBack to article page